Correlation Between Nasdaq and Artiva Biotherapeutics,
Can any of the company-specific risk be diversified away by investing in both Nasdaq and Artiva Biotherapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nasdaq and Artiva Biotherapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nasdaq Inc and Artiva Biotherapeutics, Common, you can compare the effects of market volatilities on Nasdaq and Artiva Biotherapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nasdaq with a short position of Artiva Biotherapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nasdaq and Artiva Biotherapeutics,.
Diversification Opportunities for Nasdaq and Artiva Biotherapeutics,
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Nasdaq and Artiva is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Nasdaq Inc and Artiva Biotherapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artiva Biotherapeutics, and Nasdaq is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nasdaq Inc are associated (or correlated) with Artiva Biotherapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artiva Biotherapeutics, has no effect on the direction of Nasdaq i.e., Nasdaq and Artiva Biotherapeutics, go up and down completely randomly.
Pair Corralation between Nasdaq and Artiva Biotherapeutics,
Given the investment horizon of 90 days Nasdaq Inc is expected to generate 0.21 times more return on investment than Artiva Biotherapeutics,. However, Nasdaq Inc is 4.73 times less risky than Artiva Biotherapeutics,. It trades about 0.2 of its potential returns per unit of risk. Artiva Biotherapeutics, Common is currently generating about 0.0 per unit of risk. If you would invest 5,987 in Nasdaq Inc on September 19, 2024 and sell it today you would earn a total of 1,974 from holding Nasdaq Inc or generate 32.97% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 84.8% |
| Values | Daily Returns |
Nasdaq Inc vs. Artiva Biotherapeutics, Common
Performance |
| Timeline |
| Nasdaq Inc |
| Artiva Biotherapeutics, |
Nasdaq and Artiva Biotherapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nasdaq and Artiva Biotherapeutics,
The main advantage of trading using opposite Nasdaq and Artiva Biotherapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nasdaq position performs unexpectedly, Artiva Biotherapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artiva Biotherapeutics, will offset losses from the drop in Artiva Biotherapeutics,'s long position.The idea behind Nasdaq Inc and Artiva Biotherapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Artiva Biotherapeutics, vs. Unilever PLC ADR | Artiva Biotherapeutics, vs. Acme United | Artiva Biotherapeutics, vs. Anterix | Artiva Biotherapeutics, vs. European Wax Center |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |